Intended Use
Wantai’s TB-IGRA ELISA is intended for use as an aid in the diagnosis of TB infection including both latent Tuberculosis infection and Tuberculosis disease. The test is a quantitative ELISA for detection of Interferon Gamma (IFN-γ) that responds to in-vitro stimulation by Mycobacterium Tuberculosis antigens in human blood samples.
Sample Preparation
Testing
·
Specifications
Catalog No.: WT-1196
Number of tests : 28 tests per kit
Storage temperature: 2℃ ~ 8℃
Sensitivity: Comparable to both QFT-GIT (86.4% vs 83.2%) and T-Spot (87.7% vs 88.7%)
Specificity: Comparable to both GFT-GIT(85.9% vs 88.7%) and T-Spot (81.6% vs 91.9%)
(1)
·
Recommendations
Wantai TB-IGRA ELISA is included in the Stop TB Partnership Manual on selection and use of interferon-gamma release assays (IGRAs) for testing for TB infection and in the WHO's policy statement on the use of alternative interferon-gamma release assays for the diagnosis of TB infection.
Filing Number:(京)网药械信息备字（2025）第 00190 号
|
Copyright©Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
|
京公网安备11011402010353号 
Alibaba Cloud provides cloud computing and security services.|
It supports
|
Powered by CloudDream
|
Terms Of Use|
Privacy Statement|
Statement